Citizens Commission on Human Rights International

In light of expert discussions, clinical studies, and drug regulatory agency warnings, consumers must be informed that a percentage of those taking psychotropic drugs may experience violent, even homicidal, and suicidal behavior.

The mental health watchdog says recent legislation improving oversight of youth behavioral facilities offers national hope, but warns that psychiatric hospitals involved in harm and fraud are evading justice through "no liability" deals.

The mental health industry watchdog, CCHR, says informed consent is breached every time patients are not warned of the brain damage, long-term memory loss, and cardiac risks, including death, associated with electroshock, per the study.

CCHR, a mental health watchdog, has documented psychosis and violent behavior linked to any dose of the drugs and wants them prohibited as a treatment for the 3.1 million American children put at risk by taking them.

Watchdog condemns $12 billion child and adolescent behavioral market for forcing children into psychiatric institutions, leaving parents powerless to secure their release.

New York Times exposé on unethical practices in a chain of psychiatric hospitals prompts mental health industry watchdog to push for the removal of involuntary commitment accreditation from abusive facilities and urges victims to come forward.

Mental health industry watchdog, CCHR, calls for increased legal action to protect vulnerable youth from abuses in psychiatric facilities.

Encouraged by its decline, CCHR, a patients' rights watchdog, launches a series exposing the downfall of electroshock treatment and its long-term dangers, including brain injury.

CCHR welcomes the FDA's decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to add more mind-altering drugs to a failed biomedical-based mental health system.

Mental health industry watchdog CCHR exposes new electroshock methods used in the $20 billion "ADHD" market—calls for a ban on all invasive electrical treatments